Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Böhler

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2002
Impact of the variability of cyclosporin A trough levels on long-term renal allograft functionJohannes Waiser, Torsten Slowinski, Andrea Brinker-Paschke, et al.
Artificial Organs|August 1, 2012
Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive proteinRoman Fiedler, Felix Neugebauer, Christof Ulrich, et al.
Therapeutic Drug Monitoring|February 17, 2007
Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humansTorsten Böhler, Jochen Nolting, Nassim Kamar, et al.
Clinical Immunology (Orlando, Fla.)|February 3, 2006
Profibrotic cytokines and lymphocyte proliferation in stable renal allograft recipients treated with or without cyclosporine AJohannes Waiser, Michael Schneider, Sara Eljazyfer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2009
Pharmacodynamic evaluation of the first dose of mycophenolate mofetil before kidney transplantationNassim Kamar, Petra Glander, Jochen Nolting, et al.
Kidney International|February 12, 2004
FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injuryDuska Dragun, Torsten Böhler, Melina Nieminen-Kelhä, et al.
International Immunopharmacology|April 5, 2008
Pharmacodynamic monitoring of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable kidney-allograft recipientsTorsten Böhler, Cindy Canivet, Sylvain Galvani, et al.
American Journal of Physiology. Renal Physiology|March 17, 2005
Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalaprilStephanie Krämer, Tanja Loof, Sebastian Martini, et al.
Therapeutic Drug Monitoring|September 4, 2010
Biomarkers as a tool for management of immunosuppression in transplant patientsEberhard Wieland, Christoph J Olbricht, Caner Süsal, et al.
Cytokine|January 17, 2009
Cytokines correlate with age in healthy volunteers, dialysis patients and kidney-transplant patientsTorsten Böhler, Cindy Canivet, Phuong Ngan Le Nguyen, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2002
Impact of the variability of cyclosporin A trough levels on long-term renal allograft functionJohannes Waiser, Torsten Slowinski, Andrea Brinker-Paschke, et al.
Artificial Organs|August 1, 2012
Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive proteinRoman Fiedler, Felix Neugebauer, Christof Ulrich, et al.
Therapeutic Drug Monitoring|February 17, 2007
Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humansTorsten Böhler, Jochen Nolting, Nassim Kamar, et al.
Clinical Immunology (Orlando, Fla.)|February 3, 2006
Profibrotic cytokines and lymphocyte proliferation in stable renal allograft recipients treated with or without cyclosporine AJohannes Waiser, Michael Schneider, Sara Eljazyfer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2009
Pharmacodynamic evaluation of the first dose of mycophenolate mofetil before kidney transplantationNassim Kamar, Petra Glander, Jochen Nolting, et al.
Kidney International|February 12, 2004
FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injuryDuska Dragun, Torsten Böhler, Melina Nieminen-Kelhä, et al.
International Immunopharmacology|April 5, 2008
Pharmacodynamic monitoring of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable kidney-allograft recipientsTorsten Böhler, Cindy Canivet, Sylvain Galvani, et al.
American Journal of Physiology. Renal Physiology|March 17, 2005
Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalaprilStephanie Krämer, Tanja Loof, Sebastian Martini, et al.
Therapeutic Drug Monitoring|September 4, 2010
Biomarkers as a tool for management of immunosuppression in transplant patientsEberhard Wieland, Christoph J Olbricht, Caner Süsal, et al.
Cytokine|January 17, 2009
Cytokines correlate with age in healthy volunteers, dialysis patients and kidney-transplant patientsTorsten Böhler, Cindy Canivet, Phuong Ngan Le Nguyen, et al.
Pageof 4